{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:44:58Z","timestamp":1786221898369,"version":"build-2736575974"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Renal biopsy is an essential diagnostic tool to be considered in cancer patients, a population in whom renal dysfunction is frequent, multifactorial, and clinically significant. Accurate identification of the underlying lesion is often crucial for guiding oncologic therapy, preventing further renal decline, and improving overall outcomes. However, performing a biopsy in this vulnerable patient group requires careful evaluation of procedural risks and clinical context.<\/jats:p>\n                  <jats:p>This \u201810 Tips\u2019 paper provides a practical framework to support clinicians in selecting appropriate candidates, preparing for the procedure, and interpreting histopathological findings. Special attention is given to high-risk and end-of-life scenarios, where the balance between diagnostic benefit and potential harm becomes particularly delicate. By integrating clinical, procedural, and ethical considerations, this paper aims to promote thoughtful, patient-centred approach to renal biopsy in the complex landscape of onconephrology. Shared decision-making and multidisciplinary collaboration among nephrologists, oncologists, haematologists, and pathologists are essential.<\/jats:p>","DOI":"10.1093\/ckj\/sfag218","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:45:40Z","timestamp":1785843940000},"source":"Crossref","is-referenced-by-count":0,"title":["Ten tips for kidney biopsy in cancer patients"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-9416","authenticated-orcid":false,"given":"Mariadelina","family":"Simeoni","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli , Naples ,","place":["Italy"]},{"name":"Department of Nephrology, Dialysis and Kidney Transplant Follow-up, Luigi Vanvitelli University Hospital\u00a0Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ollero","sequence":"additional","affiliation":[{"name":"Paris Est Creteil University, Cr\u00e9teil ,","place":["France"]},{"name":"Mondor Institute (INSERM U955),Institute Mondor de Recherche Biom\u00e9dicale , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-2274","authenticated-orcid":false,"given":"Clara","family":"Garcia-Carro","sequence":"additional","affiliation":[{"name":"Nephrology Department, San Carlos University Clinical Hospital , IdSSC, Madrid ,","place":["Spain"]},{"name":"Madrid Complutense University , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Bagnis","sequence":"additional","affiliation":[{"name":"Nephrology Department, AP-HP University , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kousios","sequence":"additional","affiliation":[{"name":"Nefronida Medical Centre , Nicosia ,","place":["Cyprus"]},{"name":"School of Medicine, European University of Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"van\u00a0den\u00a0Berg","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology , Utrecht ,","place":["The Netherlands"]},{"name":"Department of Pediatric Nephrology, Wilhelmina Children\u2019s Hospital\/University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-0766","authenticated-orcid":false,"given":"Maria Jose","family":"Soler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Vall Hebr\u00f3n University Hospital , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First School of Medicine and General University Hospital, Charles University , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026080816264463000_bib1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/ndt\/gfab034","article-title":"Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors","volume":"37","author":"Garc\u00eda-Carro","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.kint.2020.06.046","article-title":"KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer","volume":"98","author":"Porta","year":"2020","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib3","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/jcm11102915","article-title":"Kidney biopsy in patients with cancer along the last decade: a multicenter study","volume":"11","author":"Bolufer","year":"2022","journal-title":"J Clin Med"},{"key":"2026080816264463000_bib4","first-page":"e105813","article-title":"Kidney biopsy in cancer patients with acute kidney disease: histological findings and kidney outcomes","volume":"18","author":"Kaitantzoglou","year":"2026","journal-title":"Cureus"},{"key":"2026080816264463000_bib5","doi-asserted-by":"publisher","first-page":"1043874","DOI":"10.3389\/fneph.2023.1043874","article-title":"The need for kidney biopsy in the management of side effects of target and immunotherapy","volume":"3","author":"Fenoglio","year":"2023","journal-title":"Front Nephrol"},{"key":"2026080816264463000_bib6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.34067\/KID.0000000660","article-title":"Novel biomarkers and imaging tests for acute kidney injury diagnosis in patients with cancer","volume-title":"Kidney360","author":"Mistry","year":"2025"},{"key":"2026080816264463000_bib7","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00223-025-01344-2","article-title":"Unusual association of partial Fanconi syndrome and tumor-induced osteomalacia revealed by multiple vertebral fractures","volume":"116","author":"Debrach","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"2026080816264463000_bib9","doi-asserted-by":"publisher","first-page":"e2021328","DOI":"10.4322\/acr.2021.328","article-title":"Multiple myeloma presenting as acute tubulointerstitial nephritis","volume":"11","author":"Long","year":"2021","journal-title":"Autops Case Rep"},{"key":"2026080816264463000_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.mcna.2023.03.007","article-title":"Onco-nephrology: kidney disease in the cancer patient","volume":"107","author":"Yarandi","year":"2023","journal-title":"Med Clin North Am"},{"key":"2026080816264463000_bib11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.numecd.2020.09.013","article-title":"Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society","volume":"30","author":"Di\u00a0Paolo","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026080816264463000_bib12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-021-02457-0","article-title":"Recurrent membranous nephropathy with a possible alteration in the etiology: a case report","volume":"22","author":"Matsumoto","year":"2021","journal-title":"BMC Nephrol"},{"key":"2026080816264463000_bib13","doi-asserted-by":"publisher","first-page":"sfaf101","DOI":"10.1093\/ckj\/sfaf101","article-title":"Malignancies and glomerulonephritis: when to suspect and when to screen?","volume":"18","author":"Murt","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026080816264463000_bib15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"2026080816264463000_bib16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/diagnostics11040710","article-title":"Renal diseases associated with hematologic malignancies and thymoma in the absence of renal monoclonal immunoglobulin deposits","volume":"11","author":"Morel","year":"2021","journal-title":"Diagnostics"},{"key":"2026080816264463000_bib17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/sj.ki.5001790","article-title":"Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association","volume":"70","author":"Lefaucheur","year":"2006","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/ndt\/gfae184","article-title":"Immune checkpoint inhibitor\u2013associated nephritis\u2014treatment standard","volume":"39","author":"Barbir","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","article-title":"A systematic review of immune checkpoint inhibitor\u2013associated glomerular disease","volume":"6","author":"Kitchlu","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026080816264463000_bib20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","article-title":"Diagnosis and management of immune checkpoint inhibitor\u2013associated nephrotoxicity: a position statement from the American Society of Onco-nephrology","volume":"107","author":"Herrmann","year":"2025","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/ckj\/sfad035","article-title":"Revisiting the role of acute kidney injury in patients on immune checkpoint inhibitors: a good prognosis renal event with a significant impact on survival","volume":"16","author":"Garc\u00eda-Carro","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib22","doi-asserted-by":"publisher","first-page":"e005646","DOI":"10.1136\/jitc-2022-005646","article-title":"Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI","volume":"10","author":"Gupta","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026080816264463000_bib23","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/ijms27031240","article-title":"Urinary chemokines in the diagnosis and monitoring of immune checkpoint inhibitor-associated nephritis","volume":"27","author":"Gomez-Preciado","year":"2026","journal-title":"Int J Mol Sci"},{"key":"2026080816264463000_bib24","doi-asserted-by":"crossref","first-page":"sfae027","DOI":"10.1093\/ckj\/sfae027","article-title":"Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies","volume":"17","author":"Le\u00f3n-Rom\u00e1n","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib25","doi-asserted-by":"publisher","first-page":"sfaf270","DOI":"10.1093\/ckj\/sfaf270","article-title":"Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction","volume":"18","author":"Moncho-Franc\u00e9s","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","article-title":"Acute kidney injury in patients with cancer","volume":"376","author":"Rosner","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080816264463000_bib27","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.3390\/curroncol30080531","article-title":"Acute oncologic complications: clinical\u2013therapeutic management in critical care and emergency departments","volume":"30","author":"Gri","year":"2023","journal-title":"Current Oncol"},{"key":"2026080816264463000_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/jpm13050813","article-title":"Impact of thyroid cancer treatment on renal function: a relevant issue to be addressed","volume":"13","author":"Di\u00a0Paola","year":"2023","journal-title":"J Pers Med"},{"key":"2026080816264463000_bib29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jnci\/djy167","article-title":"Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study","volume":"111","author":"Kitchlu","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2026080816264463000_bib30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.02780312","article-title":"Onco-nephrology: renal toxicities of chemotherapeutic agents","volume":"7","author":"Perazella","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026080816264463000_bib31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ekir.2017.02.008","article-title":"Anticancer drug-induced acute kidney injury","volume":"2","author":"Izzedine","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2026080816264463000_bib32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1053\/j.ajkd.2015.04.042","article-title":"Onco-nephrology: core curriculum 2015","volume":"66","author":"Cohen","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2026080816264463000_bib33","doi-asserted-by":"publisher","first-page":"178312","DOI":"10.1016\/j.ejphar.2025.178312","article-title":"Potential role of aliskiren in cancer modulation compared to other renin-angiotensin inhibitors: an in-depth review","volume":"1008","author":"De","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"2026080816264463000_bib34","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms20205238","article-title":"The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity","volume":"20","author":"Tanase","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026080816264463000_bib35","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/10428194.2019.1697811","article-title":"Lymphomas with kidney involvement: the French multicenter retrospective LyKID study","volume":"61","author":"Kohn","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2026080816264463000_bib36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Cortazar","year":"2016","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"2026080816264463000_bib38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine"},{"key":"2026080816264463000_bib39","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.2169\/internalmedicine.5410-20","article-title":"Nephrotic syndrome with focal segmental glomerulosclerosis induced by intravitreal injections of vascular endothelial growth factor inhibitor","volume":"59","author":"Kakeshita","year":"2020","journal-title":"Intern Med"},{"key":"2026080816264463000_bib40","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","article-title":"Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature","volume":"45","author":"Usui","year":"2014","journal-title":"Hum Pathol"},{"key":"2026080816264463000_bib41","doi-asserted-by":"publisher","first-page":"sfaf394","DOI":"10.1093\/ckj\/sfaf394","article-title":"Biopsy-proven tyrosine kinase inhibitor\u2013associated renal injury: a case series","volume":"19","author":"Lian","year":"2026","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib42","doi-asserted-by":"publisher","first-page":"2590283","DOI":"10.1080\/0886022X.2025.2590283","article-title":"Anticancer drug-induced nephrotoxicity: biopsy-proven patterns and outcomes across chemotherapy, targeted therapy, and immune checkpoint inhibitors","volume":"47","author":"Tian","year":"2025","journal-title":"Ren Fail"},{"key":"2026080816264463000_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41581-025-01031-3","article-title":"The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup","volume":"22","author":"Renaghan","year":"2026","journal-title":"Nat Rev Nephrol"},{"key":"2026080816264463000_bib44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: a review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2026080816264463000_bib45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.ackd.2021.11.006","article-title":"Thrombotic microangiopathy syndromes\u2014common ground and distinct frontiers","volume":"29","author":"Hanna","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026080816264463000_bib46","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.ekir.2025.03.028","article-title":"Kidney complement immunohistochemistry in thrombotic microangiopathy subtypes","volume":"10","author":"Beckwith","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026080816264463000_bib47","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/life14070865","article-title":"Cancer-associated thrombotic microangiopathy: literature review and report of five cases","volume":"14","author":"Posado-Dom\u00ednguez","year":"2024","journal-title":"Life"},{"key":"2026080816264463000_bib48","doi-asserted-by":"publisher","first-page":"1436896","DOI":"10.3389\/fneph.2024.1436896","article-title":"Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches","volume":"4","author":"Lyrio","year":"2024","journal-title":"Front Nephrol"},{"key":"2026080816264463000_bib49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2022.03.031","article-title":"Immune checkpoint inhibitor associated renally limited thrombotic microangiopathy\u2013a clinical dilemma","volume":"169","author":"Badra","year":"2022","journal-title":"Eur J Cancer"},{"key":"2026080816264463000_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/1319-2442.279936","article-title":"Clinical profile and outcomes of De novo posttransplant thrombotic microangiopathy","volume":"31","author":"Doradla","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026080816264463000_bib51","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/ndt\/gfaf091","article-title":"Complement activation in secondary thrombotic microangiopathies","volume":"40","author":"Morelle","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib52","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood.2023022526","article-title":"A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation\u2013associated TMA","volume":"143","author":"Jodele","year":"2024","journal-title":"Blood"},{"key":"2026080816264463000_bib53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12882-025-04080-9","article-title":"Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review","volume":"26","author":"Musalem","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026080816264463000_bib54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney involvement and renal manifestations in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients","volume":"67","author":"Da\u2019as","year":"2001","journal-title":"Eur J Haematol"},{"key":"2026080816264463000_bib55","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/ndt\/gfaf139","article-title":"Kidney disease after hematopoietic stem cell transplant\u2014treatment standard","volume":"40","author":"Zhang","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib56","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41581-021-00405-7","article-title":"Kidney injury and disease in patients with haematological malignancies","volume":"17","author":"Bridoux","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026080816264463000_bib57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ajh.70104","article-title":"Parameters associated with renal recovery and survival in myeloma patients with acute renal failure to cast nephropathy","volume":"101","author":"Ludwig","year":"2026","journal-title":"Am J Hematol"},{"key":"2026080816264463000_bib58","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026080816264463000_bib59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ndt\/gfv283","article-title":"Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients","volume":"31","author":"Ecoti\u00e8re","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib60","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/S1470-2045(23)00223-1","article-title":"Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group","volume":"24","author":"Dimopoulos","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026080816264463000_bib61","doi-asserted-by":"publisher","first-page":"250","DOI":"10.7861\/clinmed.2023-RM3","article-title":"Monoclonal gammopathies of renal significance","volume":"23","author":"Gnanasampanthan","year":"2023","journal-title":"Clin Med"},{"key":"2026080816264463000_bib62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.kint.2018.10.016","article-title":"Proliferative glomerulonephritis with monoclonal Ig deposits (PGNMID): diagnostic and treatment challenges for the nephrologist!","volume":"95","author":"Kousios","year":"2019","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib63","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.xkme.2020.06.011","article-title":"Lymphoma and the kidney: a kidney biopsy teaching case","volume":"2","author":"L\u2019Imperio","year":"2020","journal-title":"Kidney Med"},{"key":"2026080816264463000_bib64","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2215\/CJN.02150212","article-title":"Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988\u20132010","volume":"7","author":"T\u00f8ndel","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026080816264463000_bib65","doi-asserted-by":"publisher","first-page":"e0269632","DOI":"10.1371\/journal.pone.0269632","article-title":"Chronic kidney disease causes and outcomes in children: perspective from a LMIC setting","volume":"17","author":"Amanullah","year":"2022","journal-title":"PLoS One"},{"key":"2026080816264463000_bib66","first-page":"e947393","article-title":"Review of paraneoplastic syndromes in children with malignancy","volume":"31","author":"Mitura-Lesiuk","year":"2025","journal-title":"Med Sci Monit"},{"key":"2026080816264463000_bib67","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/annonc\/mdm510","article-title":"Compassionate use of bevacizumab (Avastin\u00ae) in children and young adults with refractory or recurrent solid tumors","volume":"19","author":"Benesch","year":"2008","journal-title":"Ann Oncol"},{"key":"2026080816264463000_bib68","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1097\/MPH.0000000000002931","article-title":"Nivolumab-associated IgA nephropathy in a child with malignant melanoma","volume":"46","author":"Yildiz","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026080816264463000_bib69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfaf169","article-title":"Nephrotoxicity and kidney outcomes in pediatric oncology patients","volume":"41","author":"Raymakers-Janssen","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","article-title":"Acute kidney injury in pediatric cancer patients","volume":"208","author":"Park","year":"2019","journal-title":"J Pediatr"},{"key":"2026080816264463000_bib71","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1200\/JCO-24-02534","article-title":"Nephrotoxicity surveillance for childhood and young adult survivors of cancer: recommendations from the international late effects of childhood cancer guideline harmonization group","volume":"43","author":"Kooijmans","year":"2025","journal-title":"J Clin Oncol"},{"key":"2026080816264463000_bib72","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/path.6202","article-title":"Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy","volume":"261","author":"Knoppert","year":"2023","journal-title":"J Pathol"},{"key":"2026080816264463000_bib73","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12967-025-07030-z","article-title":"MicroRNA signatures of cancer risk in kidney transplant patients: insights from the COMETA study","volume":"23","author":"Simeoni","year":"2025","journal-title":"J Transl Med"},{"key":"2026080816264463000_bib74","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.21873\/anticanres.14396","article-title":"Skin architecture, kidney transplantation, and their relationship to basal and squamous cell carcinomas","volume":"40","author":"Capasso","year":"2020","journal-title":"Anticancer Res"},{"key":"2026080816264463000_bib75","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De novo malignancies after kidney transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026080816264463000_bib76","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/jcm8122189","article-title":"Management of immunosuppression in kidney transplant recipients who develop malignancy","volume":"8","author":"Yang","year":"2019","journal-title":"J Clin Med"},{"key":"2026080816264463000_bib77","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.21873\/invivo.12452","article-title":"Thrombotic microangiopathy: a rare breast cancer-associated complication treated successfully with doxorubicin and cyclophosphamide","volume":"35","author":"Jalali","year":"2021","journal-title":"In Vivo"},{"key":"2026080816264463000_bib78","doi-asserted-by":"publisher","first-page":"e1851","DOI":"10.1097\/TXD.0000000000001851","article-title":"Immune checkpoint inhibitors in kidney transplant recipients: a French multicenter retrospective cohort study","volume":"11","author":"Legris","year":"2025","journal-title":"Transplant Direct"},{"key":"2026080816264463000_bib79","doi-asserted-by":"crossref","first-page":"sfae061","DOI":"10.1093\/ckj\/sfae061","article-title":"Fine-tuning tumor-and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients","volume":"17","author":"Van\u00a0Meerhaeghe","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib80","doi-asserted-by":"publisher","first-page":"13204","DOI":"10.3389\/ti.2024.13204","article-title":"Immunotherapy for cancer in kidney transplant patients: a difficult balance between risks and benefits","volume":"37","author":"Bolufer","year":"2024","journal-title":"Transpl Int"},{"key":"2026080816264463000_bib81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.kint.2018.01.028","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft","volume":"94","author":"Said","year":"2018","journal-title":"Kidney Int"},{"key":"2026080816264463000_bib82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41408-022-00714-5","article-title":"Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group","volume":"12","author":"Havasi","year":"2022","journal-title":"Blood Cancer J"},{"key":"2026080816264463000_bib83","doi-asserted-by":"publisher","first-page":"sfaf196","DOI":"10.1093\/ckj\/sfaf196","article-title":"Major complications of percutaneous native and transplant kidney biopsy: a complete 10-year national prospective cohort study","volume":"18","author":"Geddes","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib84","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/ndt\/gfac177","article-title":"The risks associated with percutaneous native kidney biopsies: a prospective study","volume":"38","author":"Andrulli","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026080816264463000_bib85","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.ajkd.2008.05.022","article-title":"Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients","volume":"52","author":"Soares","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2026080816264463000_bib86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.ajkd.2012.02.330","article-title":"Bleeding complications of native kidney biopsy: a systematic review and meta-analysis","volume":"60","author":"Corapi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026080816264463000_bib87","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2026080816264463000_bib88","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40620-021-01204-w","article-title":"Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines","volume":"35","author":"Schulz","year":"2022","journal-title":"J Nephrol"},{"key":"2026080816264463000_bib89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000508460","article-title":"COVID-19, low-molecular-weight heparin, and hemodialysis","volume":"45","author":"Perna","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"2026080816264463000_bib90","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1002\/onco.13569","article-title":"Prediction and prevention of cancer-associated thromboembolism","volume":"26","author":"Khorana","year":"2021","journal-title":"Oncologist"},{"key":"2026080816264463000_bib91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/jcm13010031","article-title":"Role of renal biopsy in the management of renal cancer: concordance between ultrasound\/CT-guided biopsy results and definitive pathology, adverse events, and complication rate","volume":"13","author":"Isgr\u00f2","year":"2023","journal-title":"J Clin Med"},{"key":"2026080816264463000_bib92","doi-asserted-by":"publisher","first-page":"CD009445","DOI":"10.1002\/14651858.CD009445.pub2","article-title":"Interventions to promote informed consent for patients undergoing surgical and other invasive healthcare procedures","volume":"2013","author":"Kinnersley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080816264463000_bib93","first-page":"70","article-title":"End-of-life care among patients with metastatic renal cell carcinoma: importance of a patient-centric focus in clinical decision making","volume-title":"JCO Oncol Pract","author":"Bergerot","year":"2023"},{"key":"2026080816264463000_bib94","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"2026080816264463000_bib95","doi-asserted-by":"publisher","first-page":"sfae132","DOI":"10.1093\/ckj\/sfae132","article-title":"Usefulness of the clinical frailty scale in patients with end-stage kidney disease","volume":"17","author":"Lamberink","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026080816264463000_bib96","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2215\/CJN.0000000000000515","article-title":"Physical function and mortality in older adults with chronic kidney disease","volume":"19","author":"Liu","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026080816264463000_bib97","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/082585979601200102","article-title":"Palliative performance scale (PPS): a new tool","volume":"12","author":"Anderson","year":"1996","journal-title":"J Palliat Care"},{"key":"2026080816264463000_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/0886022X.2016.1244077","article-title":"Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients","volume":"39","author":"D\u2019Onofrio","year":"2017","journal-title":"Ren Fail"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag218\/70496451\/sfag218.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/8\/sfag218\/70496451\/sfag218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/8\/sfag218\/70496451\/sfag218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:26:52Z","timestamp":1786220812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag218\/8752633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag218","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,31]]},"article-number":"sfag218"}}